R15	Anaphora Anaphor:T59 Antecedent:T39
R16	Anaphora Anaphor:T63 Antecedent:T3
R17	Anaphora Anaphor:T84 Antecedent:T17
R18	Anaphora Anaphor:T84 Antecedent:T18
R19	Anaphora Anaphor:T92 Antecedent:T46
R20	Anaphora Anaphor:T96 Antecedent:T92
R21	Anaphora Anaphor:T97 Antecedent:T96
R22	Anaphora Anaphor:T106 Antecedent:T47
R23	Anaphora Anaphor:T118 Antecedent:T49
R24	Anaphora Anaphor:T120 Antecedent:T50
R25	Anaphora Anaphor:T122 Antecedent:T120
R26	Anaphora Anaphor:T135 Antecedent:T131
T3	Drug 814 821	TRENTAL
T1	Drug 994 1002	Warfarin
T4	Drug 1551 1559	Warfarin
T6	Drug 1463 1470	TRENTAL
T7	Drug 1843 1850	TRENTAL
T10	Drug 1904 1916	theophylline
T12	Drug 1928 1940	theophylline
T8	Drug_Class 1855 1884	theophylline-containing drugs
T15	Drug 2050 2062	theophylline
T17	Drug 2335 2345	nifedipine
T16	Drug 2322 2329	TRENTAL
T18	Drug 2349 2357	captopri
T21	Drug_Class 2454 2470	antihypertensive
T23	Drug_Class 2508 2531	antihypertensive agents
T27	Drug_Class 2684 2705	vitamin K antagonists
T26	Drug 2665 2679	pentoxifylline
T29	Drug 2782 2796	pentoxifylline
T30	Drug_Class 1506 1537	platelet aggregation inhibitors
T31	Drug_Class 2133 2146	beta blockers
T32	Drug_Class 2170 2189	antidiabetic agents
T33	Drug_Class 2159 2168	diuretics
T34	Drug 2148 2157	digitalis
T35	Drug 280 292	theophylline
T36	Drug_Class 1488 1502	anticoagulants
T37	Drug_Class 2195 2210	antiarrhythmics
T38	Drug 26 33	Trental
T39	Drug 84 91	TRENTAL
T40	Drug 394 401	TRENTAL
T41	Drug 552 559	TRENTAL
T42	Drug 2093 2100	TRENTAL
T43	Drug 4396 4403	TRENTAL
T44	Drug 4955 4962	TRENTAL
T45	Drug 46 60	pentoxifylline
T46	Drug 2944 2958	pentoxifylline
T47	Drug 3623 3637	Pentoxifylline
T48	Drug 4405 4419	pentoxifylline
T49	Drug 4544 4558	Pentoxifylline
T50	Drug 4661 4675	pentoxifylline
T137	SPAN 4979 4997	sufficient numbers
T57	ZeroArticleNP 0 10	Drug Label
T58	ZeroArticleNP 15 33	drug brand Trental
T59	DemonstrativeNP 230 242	this product
T60	DefiniteNP 339 353	the first sign
T61	DefiniteNP 476 485	the limbs
T62	IndefiniteNP 502 522	other manifestations
T63	PersonalPronoun 883 885	it
T64	PersonalPronoun 918 920	it
T65	IndefiniteNP 889 916	a methylxanthine derivative
T66	IndefiniteNP 933 949	some individuals
T67	DemonstrativeNP 829 849	such adverse effects
T68	DemonstrativeNP 966 980	such responses
T69	IndefiniteNP 1082 1100	other risk factors
T70	IndefiniteNP 1320 1341	a causal relationship
T71	ZeroArticleNP 1488 1502	anticoagulants
T72	ZeroArticleNP 1506 1537	platelet aggregation inhibitors
T73	IndefiniteNP 1639 1657	other risk factors
T74	IndefiniteNP 1953 1969	some individuals
T75	ZeroArticleNP 1855 1884	theophylline-containing drugs
T76	PossessivePronoun 2044 2069	their theophylline dosage
T77	DemonstrativeNP 1971 1984	Such patients
T78	ZeroArticleNP 2133 2146	beta blockers
T79	ZeroArticleNP 2159 2168	diuretics
T80	ZeroArticleNP 2170 2189	antidiabetic agents
T81	ZeroArticleNP 2195 2210	antiarrhythmics
T82	IndefiniteNP 2295 2308	some patients
T83	ZeroArticleNP 2442 2478	concomitant antihypertensive therapy
T84	DefiniteNP 2504 2531	the antihypertensive agents
T85	ZeroArticleNP 2574 2606	increased anticoagulant activity
T86	ZeroArticleNP 2684 2705	vitamin K antagonists
T87	DefiniteNP 2814 2822	the dose
T88	DemonstrativeNP 2747 2761	these patients
T89	ZeroArticleNP 2721 2743	anticoagulant activity
T90	DistributivePronoun 3129 3133	both
T91	DefiniteNP 2914 2940	the carcinogenic potential
T92	DefiniteNP 3020 3028	the drug
T93	DefiniteNP 3191 3200	the mouse
T94	DefiniteNP 3215 3223	the MRHD
T95	DefiniteNP 3227 3234	the rat
T96	DefiniteNP 3278 3286	the drug
T97	DefiniteNP 3336 3344	the drug
T98	IndefiniteNP 3388 3410	an additional 6 months
T99	ZeroArticleNP 3419 3432	drug exposure
T100	DefiniteNP 3437 3450	the rat study
T101	DefiniteNP 3545 3564	the 450 mg/kg group
T102	IndefiniteNP 3462 3498	a statistically significant increase
T103	DefiniteNP 3566 3579	The relevance
T104	DemonstrativeNP 3583 3595	this finding
T105	DefiniteNP 3796 3808	the presence
T106	PersonalPronoun 3846 3848	It
T107	DefiniteNP 3870 3905	the in vivo mouse micronucleus test
T108	PersonalPronoun 4180 4184	they
T109	DefiniteNP 4101 4112	the maximum
T110	DefiniteNP 4207 4215	the MRHD
T111	IndefiniteNP 4053 4067	a weight basis
T112	IndefiniteNP 4153 4178	a body-surface-area basis
T113	DemonstrativeNP 4069 4080	these doses
T114	DefiniteNP 4306 4325	the 576 mg/kg group
T115	DefiniteNP 4461 4482	the potential benefit
T116	DefiniteNP 4493 4511	the potential risk
T117	DefiniteNP 4515 4524	the fetus
T118	PossessivePronoun 4563 4578	its metabolites
T119	DefiniteNP 4618 4631	the potential
T120	DefiniteNP 4757 4765	the drug
T121	DefiniteNP 4787 4801	the importance
T122	DefiniteNP 4805 4813	the drug
T123	DefiniteNP 4817 4827	the mother
T124	IndefiniteNP 4685 4695	a decision
T125	PersonalPronoun 5048 5052	they
T126	DefiniteNP 5183 5194	the elderly
T127	DefiniteNP 5307 5318	the low end
T128	DefiniteNP 5322 5338	the dosing range
T129	DefiniteNP 5351 5372	the greater frequency
T130	IndefiniteNP 5248 5266	an elderly patient
T131	IndefiniteNP 5453 5471	other drug therapy
T132	DefiniteNP 5473 5494	The active metabolite
T133	DefiniteNP 5536 5546	the kidney
T134	DefiniteNP 5552 5560	the risk
T135	DemonstrativeNP 5583 5592	this drug
T136	PersonalPronoun 5769 5771	it
